Stay updated on Immunotherapy+IRE in Pancreatic Adenocarcinoma Clinical Trial

Sign up to get notified when there's something new on the Immunotherapy+IRE in Pancreatic Adenocarcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Immunotherapy+IRE in Pancreatic Adenocarcinoma Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    Change Detected
    Summary
    The study has been updated to version v2.10.0, with the previous version v2.9.7 now removed.
    Difference
    0.7%
    Check dated 2024-07-23T14:41:02.000Z thumbnail image
  5. Check
    5 days ago
    No Change Detected
  6. Check
    11 days ago
    Change Detected
    Summary
    The website has been updated to Revision v2.9.7 from v2.9.6.
    Difference
    0.2%
    Check dated 2024-07-16T08:30:10.000Z thumbnail image
  7. Check
    25 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent revision in the content of the webpage.
    Difference
    0.2%
    Check dated 2024-07-02T15:11:42.000Z thumbnail image
  8. Check
    30 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.3 to v2.9.5, indicating a recent revision in the content of the webpage.
    Difference
    0.2%
    Check dated 2024-06-27T10:59:15.000Z thumbnail image
  9. Check
    31 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.1 to v2.9.3, indicating a recent revision in the content of the webpage.
    Difference
    0.2%
    Check dated 2024-06-26T09:44:12.000Z thumbnail image
  10. Check
    32 days ago
    Change Detected
    Summary
    The value 'Show more Revision: v2.9.0' has been updated to 'Drug Information available for: Nivolumab FDA Drug and Device Resources Show less'. This change likely indicates an update in the drug information available for Nivolumab on the webpage.
    Difference
    21%
    Check dated 2024-06-25T08:52:14.000Z thumbnail image

Stay in the know with updates to Immunotherapy+IRE in Pancreatic Adenocarcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Immunotherapy+IRE in Pancreatic Adenocarcinoma Clinical Trial page.